Pfizer Bets Big on Weight Loss with $7.3B Metsera Buyout
Pfizer’s Strategic Leap into Weight Loss Market with $7.3B Metsera Acquisition Pharmaceutical titan, Pfizer, has recently declared its acquisition of Metsera, an obesity drug developer, for a staggering $7.3 billion.…
